October 6-7, 2017 Marseille, France
|
|
|
- Amberlynn Jenkins
- 6 years ago
- Views:
Transcription
1 Program Chairs M. Ahluwalia (US) E. Le Rhun (FR) P. Métellus (FR) M. Weller (CH) Scientific Committee M. Ahluwalia (US) Z. Ram (IL) F. Dhermain (FR) R. Soffietti (IT) E. Le Rhun (FR) M. Weller (CH) P. Métellus (FR) M. Westphal (DE)
2 Welcome Letter e are pleased to welcome you to Marseille for the seventh Annual Brain Metastases Research W and Emerging Therapy Conference. Last year s successful edition encouraged us to once again organize this conference. This year the meeting will be held under the auspices of EORTC, EANO and EANS. Also the French neuro-oncology group (ANOCEF) and the French society of neuro-surgery are partners of this event. This initiative brings the multidisciplinary approach needed to develop Brain Metastases projects across several tumor types and disciplines such as breast cancer, lung cancer, melanoma, imaging, radiation oncology, pathology and molecular. It is expected that this cross-sectional meeting will stimulate innovative and insightful research in a collaborative environment and improve the standard of care and methodology of clinical research. For this 7 th edition, a special session will be dedicated to Immuno-oncology in CNS Metastases. Actually, cancer immunotherapy clinical trials are critical to bringing new and potentially lifesaving treatments to more patients with more types of cancer, and may represent the greatest hope especially for patients currently facing Brain Metastases. Highlighted topics will also cover adverse radiation effect in the era of targeted therapies, new pharmalogical approaches and combined treatments in BM. One of the objectives of this edition will be to describe the clinical problem, identify the critical points of therapeutic failure and summarize the current state of knowledge of the genetics and biology of Brain Metastases. The overarching goal of the meeting is to generate a set of research priorities that would stimulate integrated scientific and clinical investigation directed at understanding basic processes of brain metastasis and translating such insights to clinical care. The organizing committee hopes that this meeting will provide an exceptional opportunity for you to share your collective expertise ranging from basic science to new treatments in order to facilitate ongoing studies and lay the foundation for future collaborative projects. PROGRAM CHAIRS: Manmeet Ahluwalia, Emilie Le Rhun, Philippe Métellus & Michael Weller
3 Scientif ic program Friday October 6 th Welcome coffee Welcome address, Philippe Métellus (France) Diagnostic approaches Chairs: Antoine Carpentier (France) & Marion Smits (The Netherlands) Molecular profiling to allocate patients to targeted clinical trials, Johan M. Kros (The Netherlands) Surgical perspectives in Brain Metastases, Manfred Westphal (Germany) Leptomeningeal Metastases, Emilie Le Rhun (France) Immuno-oncology in CNS Metastases Chairs: Anna Sophie Berghoff (Austria) & Frédéric Dhermain (France) Lessons from animal models, Manuel Valiente (Spain) Overview: immunotherapy in CNS Metastases, Manmeet Ahluwalia (USA) Toxicity of immunotherapy in CNS Metastases, Antoine Carpentier (France) Coffee break and visit of the exhibition Combined treatments for CNS Metastases Chairs: Elizabeth Moyal (France) & Zvi Ram (Israel) Combination of immunotherapy (IT) and radiotherapy (RT) in CNS Metastases, Frédéric Dhermain (France) Brain Metastases: combination of immunotherapy and other systemic pharmacotherapy, Gaetano Finocchiaro (Italy) Combination of other systemic pharmacotherapy and radiotherapy, Ulrich Herrlinger (Germany) Keynote lecture Chairs: Antoine Carpentier (France) & Ulrich Herrlinger (Germany) The future of radiotherapy for CNS Metastases: farewell to WBRT? Anthony Chalmers (United Kingdom) Lunch 13:20 Symposium Chair: Frédéric Dhermain (France) I mmunotherapy and targeted therapies in NSCLC Brain Metastases: emerging options in precision medicine EGFR TKIs in Brain Metastatases: which best therapeutic course? David Planchard (France) Immuno-oncology & radiotherapy: advances and practical issues in the management of NSCLC Brain Metastases, Elizabeth Moyal (France) Comprehensive care of patients with Brain Metastases Chairs: Gaetano Finocchiaro (Italy) & Emilie Le Rhun (France) Epilepsy in CNS Metastases: primary and secondary prevention, Roberta Rudà (Italy) Maintaining cognitive function in patients with CNS Metastases receiving multimodality treatment, Jeffrey Scott Wefel (USA) Prevention and treatment of cerebro-vascular complications, Christine Marosi (Austria) Efficacy, tolerability and safety of steroids in patients with CNS Metastases, Patrick Roth (Switzerland) Interactive case reports (progression/criteria of evaluation) Chairs: Philippe Métellus (France) & Michael Weller (Switzerland) Case 1 (Syst chemo), Amélie Darlix (France) Case 2: immune checkpoint inhibitors in Brain Metastases, Anna Sophie Berghoff (Austria) Case 3 (RT), Anouchka Modesto (France) Coffee break and visit of the exhibition Accreditation statement. 9 European CME credits (ECMEC) by the European Accreditation Council for Continuing Medical Education (EACCME) Keynote lecture Chairs: Riccardo Soffietti (Italy) & Manfred Westphal (Germany) Assessing response and clinical benefit in clinical trials enrolling patients with Brain and leptomeningeal Metastases, Michael Weller (Switzerland) Activities of EORTC BTG CNS Metastases Committee, Emilie Le Rhun (France) Guided poster walks Gala dinner
4 Scientif ic program Partners of the Conference Saturday October 7 th Welcome coffee Selected oral presentations Chairs: Anthony Chalmers (United Kingdom) & Agnès Tallet (France) New models for studies on metastatic cascades and therapy efficacy in melanoma Brain Metastases, Dayana Herrera Rios (Germany) The significance of BRAF V600E mutation status discordance between primary cutaneous melanoma and Brain Metastases: the implications for BRAF inhibitor therapy, Enda Hannan (Ireland) The role of T lymphocytes in Brain Metastases, Rute Marisa Santos Moreira Pedrosa (The Netherlands) DNA-damage response in CTCs of metastatic breast and lung cancer under radiotherapy indicates treatment response, Yvonne Goy (Germany) Factors influencing 5-ALA fluorescence intensity of cerebral Metastases, Ivan Khapov (Russia) Clinical and radiological response of BRAF- and MEK-inhibition in patients with Brain Metastases from BRAF-mutated melanoma, Dieta Brandsma (The Netherlands) Tolerance and outcomes of stereotactic radiosurgery combined with anti-pd1 (pembrolizumab) for melanoma Brain Metastases, Charlée Nardin (France) Underweight is a negative prognostic factor for patients with Brain Metastases from lung cancer, but not other primary tumors, Fabian Wolpert (Switzerland) Survival after whole brain radiotherapy for Brain Metastases from lung cancer and breast cancer is poor in 6,325 Dutch patients treated between 2000 and 2014, Paul Jeene (The Netherlands) Entrectinib, an investigational CNS-penetrating TRK-inhibitor, shows anti-tumor activity in primary and metastatic Brain tumors harboring NTRK, ROS1, and ALK gene fusions, Amélie Darlix (France) Coffee break and visit of the exhibition Highlights Chairs: Anthony Chalmers (United Kingdom) & Colin Watts (United Kingdom) Microenvironmental contributions to CNS Metastases, Adrienne Boire (USA) Neuropathology, Pieter Wesseling (The Netherlands) Imaging for Brain Metastases, Marion Smits (The Netherlands) Surgery of Brain Metastases, Philippe Métellus (France) Radiation therapy, Elizabeth Moyal (France) Perspectives in systemic treatments for BM patients, Martin J. van den Bent (The Netherlands) Awards Best communication and poster Conclusions Lunch
5
Invited Journal: Nature Medicine. Sponsors: Thermo Fisher Novocure Merck. Venue: Spanish National Cancer Research Centre CNIO Auditorium Madrid, Spain
CNIO Frontiers Meetings Primary and Secondary Brain Tumors 19th-22nd February 2017 Organisers: Richard Gilbertson CRUK Cambridge Institute, UK Michael Weller University Hospital Zurich, Switzerland Massimo
Special Situation: Brain metastases
ESMO Advanced Course on Unsolved Questions in Immuno-Oncology February 16-17 2018, Amsterdam, Netherlands Special Situation: Brain metastases Matthias Preusser, MD Associate Professor of Medicine Department
Overview: Immunotherapy in CNS Metastases
Overview: Immunotherapy in CNS Metastases Manmeet Ahluwalia, MD, FACP Miller Family Endowed Chair in Neuro-Oncology Director Brain Metastasis Research Program Cleveland Clinic Disclosures Consultant- Monteris
AOSpine Masters Symposium Novel and Emerging Technologies in Translational Medicine
EUROPE First Announcement AOSpine Masters Symposium Novel and Emerging Technologies in Translational Medicine 22-23 September 2017 Bern, Switzerland Welcome to Bern! Dear colleagues, Spinal fusions with
:00-13:00 Industry Satellite Symposium 1 Room A. 13:00-13:30 Welcome reception Hall 1. 13:30-13:45 Opening and welcome Room B
04-10-2019 12:00-13:00 Industry Satellite Symposium 1 Room A 13:00-13:30 Welcome reception Hall 1 13:30-13:45 Opening and welcome Room B 13:45-14:15 HHH Award lecture Room B 13:45-14:15 HHH Award lecture
AOSpine Masters Symposium Novel and Emerging Technologies in Translational Medicine
EUROPE First Announcement AOSpine Masters Symposium Novel and Emerging Technologies in Translational Medicine 22-23 September 2017 Bern, Switzerland SUBMIT YOUR ABSTRACT NOW! Submission closes February
ESTS SCHOOL FIRST ESTS-ERS COLLABORATIVE COURSE ON THORACIC ONCOLOGY A MULTIDISCIPLINARY UPDATE ON POTENTIALLY OPERABLE LUNG CANCER
SCHOOL FIRST -ERS COLLABORATIVE COURSE ON ONCOLOGY A MULTIDISCIPLINARY UPDATE ON POTENTIALLY OPERABLE LUNG CANCER 11-13 February 2019 Hamburg, Germany An application will be made for accreditation to European
Targeted/Immunotherapy & Molecular Profiling State-of-the-art in Cancer Care
Targeted/Immunotherapy & Molecular Profiling State-of-the-art in Cancer Care Manmeet Ahluwalia, MD, FACP Miller Family Endowed Chair in Neuro-Oncology Director Brain Metastasis Research Program Cleveland
9-10 November Nice, France
PRACTICE TEACHING COURSE SCIENTIFIC PROGRAMME Practice teaching course in head and neck cancer: focus on comprehensive management 9-10 November 2016 - Practice teaching course in head and neck cancer:
Brain metastases: future developments. Emilie Le Rhun Lille, France
Brain metastases: future developments Emilie Le Rhun Lille, France Disclosures ELR has received research grants from Mundipharma and Amgen and honoraria for lectures or advisory board participation from
3rd Annual EANS Young Neurosurgeons CME Meeting 2013
Programme 3rd Annual EANS Young Neurosurgeons CME Meeting 2013 Thursday 4th to Sunday 7th April 2013 The Royal College of Surgeons of England, London, UK Course Chairmen Mr Andreas Demetriades Consultant
Background. Molecular determinants of NSCLC radiosensi8vity are largely unkown due to limitatons current of in vitro and clinical models
Non Small Cell Lung Cancer Molecular Alterations Impact on Brain Metastases Response to Gamma Knife Radiosurgery : Identification of Potential Radiosensitive Tumor Phenotypes P. Metellus 1, S. De La Morilla
Immunotherapy for the Treatment of Brain Metastases
Society for Immunotherapy of Cancer (SITC) Immunotherapy for the Treatment of Brain Metastases Lawrence G. Lum, MD, DSc Karmanos Cancer Institute and Wayne State University Advances in Cancer Immunotherapy
LIQUID BIOPSY: TRACKING CANCER
A.R.Ger.On ONLUS SYMPOSIUM LIQUID BIOPSY: TRACKING CANCER 29-30 April 2016 prog ram Pierre-Auguste Renoir Chemin montant dans les hautes herbes SYMPOSIUM LIQUID BIOPSY: TRACKING CANCER President Paola
INNOVATIONS IN BRAIN TUMOR MANAGEMENT
APRIL 5-6, 2019 NEW YORK Memorial Sloan Kettering Cancer Center presents INNOVATIONS IN BRAIN TUMOR MANAGEMENT Rockefeller Research Laboratories 430 East 67th Street New York, New York INNOVATIONS IN BRAIN
squamous cell carcinoma of the head and neck (SCCHN)
EGFR Advisors Network (EAN) meeting for squamous cell carcinoma of the head and neck (SCCHN) Through the patients eyes March 27 28, 2015 InterContinental Hotel Berlin, Germany Chairs to include: Athanassios
ESMO Symposium on Immuno-Oncology Programme book
IMMUNO-ONCOLOGY SYMPOSIUM ESMO Symposium on Immuno-Oncology Programme book Advances in cancer immunotherapy; From vaccines to antibodies and cell therapies Geneva Switzerland 15-16 NOVEMBER 2013 esmo.org
Combined treatment of Brain metastases: Radiosurgery and Targeted therapy
Combined treatment of Brain metastases: Radiosurgery and Targeted therapy Stephanie Kroeze, MD PhD OVERVIEW Introduction brain metastases Targeted therapy as monotherapy Efficacy of SRS combined with Targeted
CLINICAL ONCOLOGY 3 RD BALKAN AND EASTERN EUROPEAN MASTERCLASS IN May 2013 Dubrovnik, Croatia. Chair: R. Popescu, CH/RO Co-chair: S.
MASTERCLASS 3 RD BALKAN AND EASTERN EUROPEAN MASTERCLASS IN CLINICAL ONCOLOGY 8-12 May 2013 Dubrovnik, Croatia Chair: Co-chair: S. Beslija, BA Aims and objectives This clinically oriented residential educational
Fondazione IRCCS, Istituto Nazionale dei Tumori. 2-4 March Milan, Italy
PRACTICE TEACHING COURSE PRELIMINARY PROGRAMME Practice teaching course in head and neck cancer, 2-4 March 2016 - Overview Head and neck cancer treatment requires multidisciplinary cooperation between
Page 1 of 5 DIAGNOSIS RISK STATUS TREATMENT WORKUP
Note: Consider Clinical Trials as treatment options f eligible patients. Signs and symptoms suggestive of leptomeningeal metastases Leptomeningeal Metastases WORKUP Physical exam with comprehensive neurologic
2015 EUROPEAN CANCER CONGRESS
2015 EUROPEAN CANCER CONGRESS 25-29 September 2015 Vienna, Austria SUMMARY The European Cancer Congress (ECC 2015) combined the 40th European Society for Medical Oncology (ESMO) congress with the 18th
surger-i-nnsbruck Multidisciplinary Management of the Pancreas Educational Meeting on Surgical Diseases of the Pancreas Programme
www.hpb-innsbruck.at surger-i-nnsbruck Multidisciplinary Management of the Pancreas Educational Meeting on Surgical Diseases of the Pancreas congress innsbruck Rennweg 3 6020 Innsbruck Programme General
Treating Multiple. Brain Metastases (BM)
ESTRO 36 5-9 May 2017, Vienna Austria, Accuray Symposium Treating Multiple Brain Metastases (BM) with CyberKnife System Frederic Dhermain MD PhD, Radiation Oncologist Gustave Roussy University Hospital,
Colorectal Cancer Multidisciplinary management, standards of care and future perspectives
ESMO Preceptorship Programme Colorectal Cancer Multidisciplinary management, standards of care and future perspectives Prague, Czech Republic 6-7 July 2016 CO-CHAIRS: Andrés Cervantes, Spain Jean-Yves
October 12 13, 2018 New York Marriott Marquis New York, New York. The premier conference for annual updates in lung cancer. 23rd Annual Conference
The premier conference for annual updates in lung cancer 23rd Annual Conference October 12 13, 2018 New York Marriott Marquis New York, New York Reserve your place today: thoraciccancermeeting.com Perspectives
ESMO-Christie Lung Cancer Course
SMO-Christie Lung Cancer Course Wednesday 12th - Friday 14th February 2014 ducation Centre (Dept 17), The Christie, Manchester, M20 4BX This event is a joint initiative between The uropean Society for
Organized by. Scientific comittee
July 11 & 12, 2019 Institut Pasteur Organized by Arun Sanyal Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA Lawrence Serfaty Hôpital Hautepierre Hôpitaux Universitaires de
31 st Annual Meeting Chicago 2018 Preliminary Program
June 20 June 22, 2019 Northwestern University, Chicago, Illinois USA 15:00-18:00 SLTBR Board Meeting 31 st Annual Meeting Chicago 2018 Preliminary Program Wednesday, June 19 th 8:30-9:00 Registration Thursday,
EORTC LUNG CANCER GROUP GROUP MEETING
Sunday 7 th October 2018 Time slot Topic / Title of presentation Chair 9.00 11.00 Board meeting 11.00 11.30 Arrivals & Welcome coffee 11.30 11.50 Welcome & Introduction New Board,, Membership status, Calendar
UCLA Radiation Oncology Workshop: Integration of State-of-the-Art Innovations into Clinical Radiation Oncology Practice June 9-10, 2017
UCLA Workshop: Integration of State-of-the-Art Innovations into Clinical Radiation Practice June 9-10, 2017 Neuroscience Research Building Auditorium (NRB) UCLA Campus Los Angeles, California UCLA Workshop:
Clinical utility of precision medicine in oncology
Clinical utility of precision medicine in oncology Prof. Christophe Le Tourneau, MD, PhD Institut Curie Paris & Saint-Cloud France Head, Department of Drug Development and Innovation (D 3 i) INSERM U900
CDx in oncology Prof. Christophe Le Tourneau, MD, PhD FEAM Geneva September 27, 2018
CDx in oncology Prof. Christophe Le Tourneau, MD, PhD Institut Curie Paris & Saint-Cloud France Head, Department of Drug Development and Innovation (D 3 i) INSERM U900 Research unit Versailles Saint-Quentin-en-Yvelines
July 5 & 6, 2018, Paris SCIENTIFIC PROGRAM
www.paris-nash.org Dear Colleagues, We are delighted to announce the 4th Paris NASH Meeting to be held on July 5-6 th 2018. This international academic meeting is aimed to do a deep-dive into many aspects
SCIENTIFIC PROGRAMME SNOLA THE STATE OF THE ART ON NEURO-ONCOLOGY th March
SCIENTIFIC PROGRAMME SNOLA THE STATE OF THE ART ON NEURO-ONCOLOGY 2018 15th March 13h 13h45 ROOM 1 ROOM 2 ROOM 3 Imaging and pathology case discussion Lymphomas case discussion- Meningeomas Moderator:
Friday 20 April 2018 Pre congress meetings
Programme Overview *7 March 2018 20-24 April 2018 Melbourne Convention and Exhibition Centre, Australia Friday 20 April 2018 Pre congress meetings * Room allocations are subject to change 0070 2030 Registration
Amphithéâtre Bordeaux. Amphithéâtre. C. Massard, Villejuif, CEDEX/FR. N. Rizvi, New York, NY/US
25.02.2019 08:45-09:30 Opening and welcome + Honorary award Keynote lecture 08:45-08:55 Welcome address 08:55-09:00 Presentation of the TAT 2019 Honorary Award 09:00-09:30 TAT 2018 Honorary Award Keynote
The 2016 Northwestern Brain Tumor Institute
The 2016 Northwestern Brain Tumor Institute CME Symposium Friday, April 1 Chicago, Illinois 7:15 am 3:00 pm Sponsored by Northwestern Medicine Brain cancer is a rare type of cancer, accounting for only
S. Rauh 1, J. Douillard 2 ; 1 Esch Sur Alzette, LU, 2 Lugano - Viganello, CEDEX/CH
27.04.2018 10:30-10:45 Opening and welcome Sala B Moderation: S. Rauh, J. Douillard ; Esch Sur Alzette, LU, Lugano - Viganello, CEDEX/CH 10:30-10:45 Welcome to the Symposium S. Rauh 1, J. Douillard 2 ;
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES
PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES CENTRAL NERVOUS SYSTEM BRAIN METASTASES CNS Site Group Brain Metastases Author: Dr. Norm Laperriere Date: February 20, 2018 1. INTRODUCTION
The 30 th Annual Meeting Groningen 2018 Preliminary Program
Hanzeplein 1, 9713 GZ Groningen Netherlands The 30 th Annual Meeting Groningen 2018 Preliminary Program Thursday, June 21 st 8:45-12:30 8:45-9:00 9:00-9:45 Room 5161.0253, Bernoulliborg, Zernike Campus
Precision medicine for gliomas
Precision medicine for YAZMIN ODIA, MD MS LEAD PHYSICIAN OF MEDICAL NEURO-ONCOLOGY DISCLOSURES Novocure: Advisory Board for Optune in No other financial conflicts of interest Glioma OVERVIEW INFILTRATIVE,
6-8 July Naples, Italy
PRACTICE TEACHING COURSE SCIENTIFIC PROGRAMME Metastatic colorectal cancer: from disease biology to clinical management 6-8 July 2016 - Naples, Italy Metastatic colorectal cancer: from disease biology
Brain metastases and meningitis carcinomatosa: Prof. Rafal Dziadziuszko Medical University of Gdańsk, Poland
Brain metastases and meningitis carcinomatosa: a palliative situation? Prof. Rafal Dziadziuszko Medical University of Gdańsk, Poland SAMO, Lucerne, February 1-2, 2013 Treatment options for NSCLC patients
Friday 20 April Pre-congress meetings
Programme Overview *8th February 2018 Friday 20 April 2018 - Pre-congress meetings * Room allocations are subject to change 0070-2030 Registration open Exhibition Concourse, MCEC Room Plenary 2 Room 216
Friday 20 April Pre-congress meetings
Programme Overview *27th February 2018 12th Congress of the World Federation of Nuclear Medicine and Biology 20-24 April 2018 Melbourne Convention and Exhibition Centre, Australia Friday 20 April 2018
SCIENTIFIC TIMETABLE SIOP 2015
SCIENTIFIC TIMETABLE SIOP 2015 September, 2015 WEDNESDAY, 7 TH OCTOBER 2015 / DAY 2 1.43 09:30 SIOP Committee 12:00 SIOP Essential Drugs Working 13:00 SIOP Work (Open) 14:00 Nurse Researchers 16:00 17:00
Gastrointestinal Oncology
2 nd MD ANDERSON INTERNATIONAL MEETING IN Gastrointestinal Oncology CURRENT PRACTICE AND CONTROVERSIES in the Era of Personalized Medicine e Madrid, 13 th -15 th November, 2019 SCIENTIFIC PROGRAM Meeting
PRECEPTORSHIP PROGRAMME
esmo.org PRECEPTORSHIP PROGRAMME Gastrointestinal Tumours Multidisciplinary management, standards of care and future perspectives SINGAPORE 20-22 OCTOBER 2016 Co-Chairs Jean-Yves Douillard, Switzerland
2017 Northwestern Brain Tumor Institute
Chicago, Illinois 7:15 am 2:00 pm Sponsored by Northwestern Medicine Established in 2008, Northwestern (NBTI) unites the expertise and resources of specialists across a wide range of disciplines to develop
EANO ANNUAL REPORT 2016 EUROPEAN ASSOCIATION OF NEURO-ONCOLOGY. Content
EANO EUROPEAN ASSOCIATION OF NEURO-ONCOLOGY ANNUAL REPORT 2016 Content Preface......................................... 2 EANO Executive Board 2016-2018..................... 2 Scientific Committee................................
Update in Breast Imaging
Update in Breast Imaging 26-28 April 2018 Site Oud Sint-Jan Bruges, Belgium Final Programme Visiting President: Debra M. Ikeda Stanford University School of Medicine, Stanford, USA www.update-medical-imaging.be
Friday 20 April pre-congress meetings
Programme Overview * 8 January 2018 12th Congress of the World Federation of Nuclear Medicine and Biology 20-24 April 2018 Melbourne Convention and Exhibition Centre, Australia Friday 20 April 2018 - pre-congress
Case Studies. Ravi Salgia, MD, PhD
Case Studies Ravi Salgia, MD, PhD Professor and Arthur & Rosalie Kaplan Chair Medical Oncology and Therapeutics Research Associate Director for Clinical Sciences Research City of Hope 04-21-2018 Objectives
RADIATION ONCOLOGY 3 RD ESO-ESTRO MASTERCLASS IN. 3-8 November 2012 Milan, Italy FIRST ANNOUNCEMENT
MASTERCLASS MILAN 03/11/12 3 RD ESO-ESTRO MASTERCLASS IN RADIATION ONCOLOGY 3-8 November 2012 Milan, Italy Chair: M. Baumann, DE - J. Bernier, CH - R. Orecchia, IT R. Pötter, AT FIRST ANNOUNCEMENT Aims
TUESDAY, 18th OCTOBER, 2016 / DAY -2
Legend: Keynote Educational PODC Symposium Meet the Expert (MTE) Paediatric Psycho-Oncology () Opening/Closing Award Session Free Paper Session (FPS) Session Satellite Symposium SIOPe GA SIOP ABM Late
Impact of Targeted/Immunotherapy on Gamma Knife Radiosurgery
Impact of Targeted/Immunotherapy on Gamma Knife Radiosurgery Veronica Chiang, MD Yale University Department of Neurosurgery IGKRF Scientific Session University of Pennsylvania, Philadelphia June 23-24,
Chair: W. Eberhardt, DE; S. Peters, CH. 12:00-13:00 Industry Satellite Symposium 1 (TBC) Room A. 13:30-13:45 Opening and Welcome Room B
13-04-2016 12:00-13:00 Industry Satellite Symposium 1 (TBC) Room A 13:30-13:45 Opening and Welcome Room B Chair: W. Eberhardt, DE; S. Peters, CH 13:45-14:15 Heine H. Hansen Award Lecture Room B 14:30-16:00
Agilent companion diagnostics for cancer immunotherapy
Agilent companion diagnostics for cancer immunotherapy Annika Eklund, PhD Global Product Manager Companion Diagnostics Agilent Technologies Aalborg 1 Agilent Trusted Answers. Together OUR FOCUS life sciences,
Residual Cancer. May 3-5, International Symposium. on Minimal. Le Corum. > Preliminary. Program MONTPELLIER, FRANCE
International Symposium th on Minimal Residual Cancer > Preliminary Program May 3-5, 2018 Le Corum MONTPELLIER, FRANCE Organizers: www.ismrc2018.com > Committee & Speakers > Welcome to Montpellier Scientific
3rd Annual UCLA State-of-the-Art in Neuro-Oncology
3rd Annual UCLA State-of-the-Art in Neuro-Oncology February 10, 2018 Tamkin Auditorium Ronald Reagan UCLA Medical Center Los Angeles, California Course Description The Brain Tumor Center at the David Geffen
VIAREGGIO 08/04/11 GENE PROFILING IN CLINICAL ONCOLOGY. 8-9 April 2011 Viareggio, Italy. Chair: M. Aapro, CH
ESO ADVANCED COURSES, SEMINARS AND SYMPOSIA VIAREGGIO 08/04/11 GENE PROFILING IN CLINICAL ONCOLOGY 8-9 April 2011 Viareggio, Italy Chair: M. Aapro, CH Dear Colleagues, The European School of Oncology is
Neurosurgery UPDATE 2018 APRIL 13-14, 2018 LOEWS SANTA MONICA BEACH HOTEL Ocean Ave, Santa Monica, CA
UPDATE 2018 APRIL 13-14, 2018 LOEWS SANTA MONICA BEACH HOTEL 1700 Ocean Ave, Santa Monica, CA COURSE DIRECTORS Nader Pouratian, MD, PhD Associate and Vice Chair Division of Functional UCLA Department of
Targeted Therapies in Lung Cancer Patient Forum
Targeted Therapies in Lung Cancer Patient Forum Welcome! What to expect today Experts in EGFR, ALK, ROS1, BRAF, MET, and RET+ lung cancers will be presenting and interacting with patients and caregivers.
31 st Annual Meeting Chicago 2019 Preliminary Program V18
June 20 June 22, 2019 Northwestern University, Chicago, Illinois USA 31 st Annual Meeting Chicago 2019 Preliminary Program V18 Wednesday, June 19 th 15:00-18:00 SLTBR Board Meeting Thursday, June 20 th
6 TH ESO-SIOP EUROPE MASTERCLASS IN PAEDIATRIC ONCOLOGY June 2016 Berlin, Germany. Chairs: A. Eggert, DE B. Morland, UK R.
MASTERCLASS 6 TH ESO-SIOP EUROPE MASTERCLASS IN PAEDIATRIC ONCOLOGY Held with the support of 11-16 June 2016 Berlin, Germany Chairs: A. Eggert, DE B. Morland, UK R. Riccardi, IT INTRODUCTION ESO and SIOP-Europe
Surgery for recurrent brain metastases
Surgery for recurrent brain metastases Pr Philippe METELLUS Neurosurgeon, Clairval Hospital Center, Marseille 8th Annual Brain Metastases Research and Emerging Therapy Conference September 21st, 2018 Conflict
1st Annual UCLA State-of-the-Art in Neuro-Oncology
1st Annual UCLA State-of-the-Art in Neuro-Oncology Part 2 Brain and Spine Metastases: A Comprehensive, Multidisciplinary Approach Saturday, December 12, 2015 NRB Auditorium Neuroscience Research Building
Making a Difference. Highest quality care. Education. Research. Innovation. OUR MISSION:
Making a Difference Highest quality care. Education. Research. Innovation. OUR MISSION: To deliver world-class care on a daily basis to our patients using the most advanced technologies available. To conduct
S. Rauh 1, J. Douillard 2 ; 1 Esch Sur Alzette, LU, 2 Lugano - Viganello, CEDEX/CH
27.04.2018 10:30-10:45 Opening and welcome Sala B Moderation: S. Rauh, J. Douillard ; Esch Sur Alzette, LU, Lugano - Viganello, CEDEX/CH 10:30-10:45 Welcome and introduction S. Rauh 1, J. Douillard 2 ;
Virtual Journal Club: Front-Line Therapy and Beyond Recent Perspectives on ALK-Positive Non-Small Cell Lung Cancer.
Virtual Journal Club: Front-Line Therapy and Beyond Recent Perspectives on ALK-Positive Non-Small Cell Lung Cancer Reference Slides ALK Rearrangement in NSCLC ALK (anaplastic lymphoma kinase) is a receptor
Society for Immunotherapy of Cancer (SITC) Immunotherapy for the Treatment of Brain Metastases
Society for Immunotherapy of Cancer (SITC) Immunotherapy for the Treatment of Brain Metastases Geoffrey T. Gibney, MD Georgetown-Lombardi Comprehensive Cancer Center Medstar-Georgetown University Hospital
SCOTTISH ONCOLOGY SUMMIT Double Tree by Hilton, Dunblane Hydro, Dunblane 1 st - 2 nd September 2017
Friday 1 st September 1300h 1400h Lunch (arrival, registration at conference foyer, coffee and sponsors exhibition) 1400h 1420h Prof Robert Jones Welcome/Announcements 1430h 1600h Parallel sessions: Lung
Current Techniques in the Treatment of Severe Endometriosis
in the Treatment of Severe Endometriosis September 5 th to 7 th, 2011 Director: A. Wattiez France Faculty: J. Alcocer Mexico S. Barata Portugal M. Canis France J. Dequesne Switzerland H. Ferreira Portugal
Hall 406. Title: Opening & Keynote. Hall 405. Title: Treatment of node positive bladder. Hall 404
23-11-2018 10:00-11:30 Type: Opening session Title: Opening & Keynote Hall 406 11:45-12:30 Type: Challenge Your Expert session Title: Treatment of node positive bladder 11:45-11:55 Treatment of node positive
NSCLC: immunotherapy as a first-line treatment. Paolo Bironzo Oncologia Polmonare AOU S. Luigi Gonzaga Orbassano (To)
NSCLC: immunotherapy as a first-line treatment Paolo Bironzo Oncologia Polmonare AOU S. Luigi Gonzaga Orbassano (To) The 800-pound gorilla Platinum-based chemotherapy is the SOC for 1st-line therapy in
ESMO-ESO Course on Medical Oncology for Medical Students Educational Programme July 2016, Valencia, Spain
ESMO-ESO Course on Medical Oncology for Medical Students Educational Programme 14-19 July 2016, Valencia, Spain Co-chairs: Andrés Cervantes, ES - Nicholas Pavlidis, GR - Susana Banerjee, UK Thursday, 14
07:00-07:10 Clinical potential of mirnas and their targets in NSCLC
9th European Regional Conference on Thoracic Oncology: New challenges in diagnosis and treatment 16-17 June 2017 Hotel Holiday Inn Vilnius Conference Program Friday, June 16, 2017 7:00 8:30 Young investigators
MEDICAL ONCOLOGY ESO-ESMO EASTERN EUROPE AND BALKAN REGION MASTERCLASS IN. 27 June - 2 July 2014 Brdo, Slovenia. Chairs: T. Cufer, SI R.
Flyer MMO_(4 Mar)_screen 04.04.2014 09:33 Pagina 3 MASTERCLASS ESO-ESMO EASTERN EUROPE AND BALKAN REGION MASTERCLASS IN MEDICAL ONCOLOGY 27 June - 2 July 2014 Brdo, Slovenia Chairs: R. Herrmann, CH This
Update on public hearing
Update on public hearing PCWP/HCPWP joint meeting Presented by Juan Garcia Burgos on 0 September 017 Head of Public Engagement Department An agency of the European Union A public hearing provides An opportunity
Changing Treatment Paradigms with Immunotherapy and Targeted Therapy in Advanced Non-Small-Cell Lung Cancer and Head & Neck Cancer
Saturday, October 27, 2018 7:00 AM - 3:45 PM Changing Treatment Paradigms with Immunotherapy and Targeted Therapy in Advanced Non-Small-Cell Lung Cancer and Head & Neck Cancer Program Director John V.
PRELIMINARY PROGRAMME H&N Preceptorship: focus on comprehensive management Nice, France
PRELIMINARY PROGRAMME H&N Preceptorship: focus on comprehensive management Live educational course dates The live educational course H&N Preceptorship: Focus on comprehensive management" will be held on
TUESDAY, 18th OCTOBER, 2016 / DAY -2. THE SPENCER HOTEL Hall A Hall B (St. Lukes Hospital)
Legend: Keynote Educational Meet the Expert (MTE) Paediatric Psycho-Oncology () Opening/Closing Award Session Free Paper Session (FPS) Session Satellite SIOPe GA SIOP ABM Late Breaker Session Networking
SCIENTIFIC PROGRAM. ASCO Direct 15CME HOURS. SCfHS ACCREDITED FOR. Current Update Sponsored by:
ASCO Direct Current Update 2017 24-25 November 2017 Crowne Plaza Hotel, Jeddah, KSA SCIENTIFIC PROGRAM Organized by: SCfHS ACCREDITED FOR 15CME HOURS Licensed by: Sponsored by: (+966) 11 462 2515 Ext.
17-18 October Dubai, UAE
PRELIMINARY PROGRAMME Evidence based medicine in metastatic colorectal cancer workshop 17-18 October 2014 - Dubai, UAE Dear participant, A warm welcome to all attending the Evidence based medicine in metastatic
Nieuwe behandelingsmethodes in de oncologie
Nieuwe behandelingsmethodes in de oncologie Vibeke Kruse MD PhD Medical Oncologist Clinical Pharmacologist Department of Medical Oncology UZ Gent 20 Juni 2017 Outline 1) Introduction 2) Systemic therapy
Clinical response to entrectinib in a patient with NTRK1-rearranged non-small cell lung cancer (NSCLC)
Clinical response to entrectinib in a patient with NTRK1-rearranged non-small cell lung cancer (NSCLC) Anna F. Farago, Manish Patel, Todd M. Bauer, Stephen V. Liu, Alexander Drilon, Jennifer Wheler, Sai-Hong
Multidisciplinary Spine Oncology Symposium
Multidisciplinary Spine Oncology Symposium Friday-Saturday, April 7-8, 2017 Memorial Sloan Kettering Cancer Center Zuckerman Research Center 417 East 68th Street New York, NY 10065 Multidisciplinary Spine
Leptomeningeal metastasis: management and guidelines. Emilie Le Rhun Lille, FR Zurich, CH
Leptomeningeal metastasis: management and guidelines Emilie Le Rhun Lille, FR Zurich, CH Definition of LM LM is defined as the spread of tumor cells within the leptomeninges and the subarachnoid space
ESSO Advanced Course on Breast Cancer Surgery
ESSO Advanced Course on Breast Cancer Surgery 08-10 October 2015 LISBON In Partnership with ESSO Advanced Course on Breast Cancer Surgery Chairs Marjut Leidenius, Helsinki University Central Hospital,
Efficacy of anti-pd-1 therapy in patients with melanoma brain metastases
Efficacy of anti-pd-1 therapy in patients with melanoma brain metastases John J. Park 1, Sagun Parakh 2,3,4, Shehara Mendis 5, Rajat Rai 6, Wen Xu 7, Serigne Lo 6, Martin Drummond 6, Catherine Rowe 7,
MEETING PROSPECTUS www.virology-education.com CONTENT Introduction... 3 Workshop description... 4 Background...4 Meeting Objectives...4 Learning Objectives...4 Format...4 Unique Meeting Features...4 Target
CANCER BIOLOGY FOR CLINICIANS
www.esmo.org/events CANCER BIOLOGY FOR CLINICIANS Symposium Nice, France 26-27 November 2010 Program Book 1 Organization and contacts Organization, Program, Registration ESMO Head Office c/o ESMO Congress
Highlights from AACR 2015: The Emerging Potential of Immunotherapeutic Approaches in Non-Small Cell Lung Cancer
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
B. Mark Evers, MD Director, Markey Cancer Center University of Kentucky
April 13 Time Topic Speaker 8-8:30 Welcomes Robert DiPaola, MD, PhD Dean, College of Medicine B. Mark Evers, MD Director, Markey Cancer Center 8:30-9:00 Overview of Immunology and Basis of Immunotherapy
OVARIAN. CANCER Optimal Therapy. Update ADVANCED. 12 th International Symposium. Valencia, 22 nd February
Organized by Valencia, 22 nd February 2019 12 th International Symposium ADVANCED OVARIAN CANCER Optimal Therapy. Update DIRECTORS Andrés Poveda Initia Oncology, Hospital Quirónsalud, Valencia, Spain Jan
Part 1 Primary Brain Tumors Saturday, August 22, 2015 Tamkin Auditorium Ronald Reagan UCLA Medical Center Los Angeles, California
1st Annual UCLA State-of-the-Art in Neuro-Oncology Part 1 Primary Brain Tumors Saturday, August 22, 2015 Tamkin Auditorium Ronald Reagan UCLA Medical Center Los Angeles, California Course Description The
Quality and Safety Initiatives for Radiation Oncology in Europe: different approaches, united view.
Quality and Safety Initiatives for Radiation Oncology in Europe: different approaches, united view. Yolande Lievens, MD, PhD Chair Radiation Oncology Department, Ghent University Hospital Co-Chair HERO
Version 1.11 of 20/07/2018
Version 1.11 of 20/07/2018 NICE JANUARY 17-19, 2019 6 th International Workshop on Lung Health New approaches to respiratory diseases PRESIDENTS: F. BLASI, G.W. CANONICA CHAIRMEN: S. CENTANNI, J.C. VIRCHOW,